Congress Asset Management CO Tango Therapeutics, Inc. Transaction History
Congress Asset Management CO
- $14.3 Billion
- Q4 2024
A detailed history of Congress Asset Management CO transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 227,989 shares of TNGX stock, worth $763,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227,989
Previous 209,070
9.05%
Holding current value
$763,763
Previous $1.61 Million
56.25%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
126Shares Held
91.8MCall Options Held
3.1KPut Options Held
1.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$56.5 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$44.7 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$27.5 Million3.35% of portfolio
-
Nextech Invest Ag5.53MShares$18.5 Million6.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.02MShares$16.8 Million0.02% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $295M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...